JW Pharmaceutical Corporation
Records under this name other than the patents JW Pharmaceutical Corporation holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 12 patents it holds.
Showing 1 to 3 of 3 · Back to JW Pharmaceutical Corporation
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,623,348 | Interferon-α (IFN-α) fused proteins comprising IFN-α and a cytoplasmic transduction peptide (CTP) Formerly held Lapsed on the fee record Ended Jan 7, 2026 · USPTO record | Lapsed on the fee record | Ended Jan 7, 2026 | USPTO record |
| US 9,393,201 | Oxaliplatin nanoparticles and method for preparing same Lapsed on the fee record Ended Jul 19, 2020 · USPTO record | Lapsed on the fee record | Ended Jul 19, 2020 | USPTO record |
| US 8,383,355 | COMBINATION OF sPLA2 TYPE IIA MASS AND OXPL/APOB CARDIOVASCULAR RISK FACTORS FOR THE DIAGNOSIS/PROGNOSIS OF a CARDIOVASCULAR DISEASE/EVENT Formerly held Lapsed on the fee record Ended Feb 26, 2017 · High confidence | Lapsed on the fee record | Ended Feb 26, 2017 | High confidence |